USX:ALVO - Alvotech Alvotech
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 21 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 13.5    +0.0 (+0%)

17 May 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Faysal Kalmoua

IPO: 2022-06-16

Headquarters: US

Employees: 999

Homepage

Description

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms